Asthma is a common and important disease, characterized by widespread bronchial obstruction that is reversible either spontaneously or with therapy. Its principal causes seem to be allergy, infections, irritants, and psychophysiologic reactions, usually in combinations. Induction of asthma by allergens is related to the presence of IgE antibodies fixed to mast cells and basophils. When these antibodies react with allergens, histamine and slow-reacting substance of anaphylaxis are released from the mast cells. There is also evidence of disturbance of control of the bronchi by the autonomic nervous system. Probably both increased cholinergic and decreased beta adrenergic effects are contributors. Some common manifestations of asthma have not been widely appreciated until recently. Hypoxia, due to altered ventilation-perf usion relationships, is nearly always present in severe asthma. Exercise-induced bronchospasm, of not yet completely understood origin, is a common problem for asthmatics and can usually be prevented by prophylactic administration of a bronchodilator.
DR. GILDON N. BEALL*: Our understanding of asthma has been significantly improved in recent years. This conference reviews some of the new ideas and insights.
The American Thoracic Society Committee on Diagnostic Standards for Nontuberculous Respiratory Diseases offers the most widely accepted definition of asthma: "Asthma is a disease characterized by an increased responsiveness of the trachea and bronchi to various stimuli and manifested by a widespread narrowing of the airways that changes in severity either spontaneously or as a result of therapy" (1) . The important words in the definition are "widespread narrowing of the airways" and "changes in severity." The definition of asthma quite properly does not mention cause and does not include nonreversible bronchial obstructive disease or episodic dyspnea unrelated to bronchial obstruction.
The complexity of the situation is shown by examination of a cross section of an asthmatic bronchus ( Figure 1 ). The problem does not reside solely with the smooth muscle, although this does appear to be thickened. In addition, the basement membrane is thickened, there is an increase in the size and number of submucosal mucus glands, and there are larger numbers of goblet cells. Finally, the epithelium is desquamated, and the bronchial lumen is filled with plugs composed of epithelial debris, eosinophils, and inspissated mucus. Obviously, the mucus plugging and the glandular changes are not rapidly reversible -a point that needs emphasis in assessing the results of therapy in asthma.
Asthma is a common disease. The 1958 U.S. National Health Survey revealed a prevalence of 2.3% (2); it is equally common in other countries. About 65% of children who have asthma develop their asthmatic symptoms before age 5. The onset is often associated with an infection, in particular, bronchiolitis due to respiratory syncytial virus. In childhood, the disease is more common in boys than in girls by a 2:1 ratio. In contrast, physicians dealing with adult asthmatics see a majority of female patients. This probably does not represent the true state of affairs, since women probably seek a physician's assistance more readily than do men.
The prognosis of childhood asthma is good. Rackemann and Edwards (3) were able to obtain information from 90% of a personally treated series of 449 patients seen first before they were 14 years old. Twenty years later, only 30% of these patients still suffered from the disease. Of the 70% in remission, one third still found it necessary to avoid things that seemed to cause their asthma. Despite this high remission rate, the frequency of the disease in adults appears to be similar to that in childhood. This agrees with clinical impressions that in at least half of the adult patients with asthma the disease has its onset in adult life.
The asthma mortality in Rackemann's group of asthmatics was 2% for 20 years, or 0.1% annually. Similar figures have been obtained in other studies in the United States and Scandinavia. Asthmatic patients with recurrent episodes of status asthmaticus have an increased mortality risk, 3.3% annually in one study. Although these figures demonstrate that the disease is not benign, death does not accurately reflect asthma's true importance, which lies more in its impact on the individual patient. His illness, time lost from work or school, and general impairment of the quality of his life have great import not only for him but also for his family and the community.
IgE in Asthma and in Health
Dr. Douglas C. Heiner*: Let us consider the role of IgE antibodies in bronchial asthma, as well as their possible significance in broader aspects of medicine. We can begin by reviewing-a few historical milestones.
Asthma was recorded in medical literature before the time of Christ, but there was little insight into its nature until the rudiments of immunology were recognized near the end of the 19th century. Early in the 20th century, von Pirquet (4) coined the term allergy to signify an altered responsiveness to a foreign substance, including not only responses of the anaphylactic type but also responses to bacterial antigens such as tuberculin. We now know that delayed hypersensitivity reactions to bacterial antigens are to be expected, and only the unusual person retains a negative delayed skin reaction after certain infections. For many, therefore, the term "allergy" has come to mean an unusual clinical response to a foreign antigen (or allergen). This definition of allergy is clinically useful and is not restricted to responses involving IgE but permits inclusion of disorders such as contact dermatitis a delayed hypersensitivity reaction, and others for which the mechanism is uncertain. It is also likely that certain IgE-mediated responses occur in normal subjects. These should not be considered to represent allergic reactions unless they are exaggerated or involve unfavorable symptoms.
In 1919 Ramirez (5) unwittingly performed an interesting experiment when he gave a blood transfusion to an anemic man. The patient had no trouble with wheezing or allergy before, but after the transfusion nearness to horses caused him to wheeze. This surprised Ramirez, who was sufficiently impressed to investigate the blood donor, and he found him to be exquisitely horse-sensitive. This may have been the first recorded clinical demonstration of the passive transfer of immediate-type hypersensitivity in human beings.
In 1921 Prausnitz and Kustner (6) experimented on each other. One of them had marked clinical sensitivity to fish and a positive skin test to fish extract. When he injected a small volume of his serum into the skin of his co-worker and challenged this site and normal skin sites with fish extract, an inflammatory reaction appeared only where serum had been passively injected. This type of local passive transfer of immediate hypersensitivity is now known as the Prausnitz-Kustner or PK reaction.
In 1923 Coca and Cooke (7) coined the term atopy to describe the symptoms of allergic asthma, hay fever, eczema, or urticaria, one or more of which frequently occurred in several members of the same family. The term reagin was introduced to indicate the serum factor described by Prausnitz and Kustner, which was thought to be responsible for the atopic state.
Beginning in 1926, Walzer and Brunner (8, 9) studied the PK reaction by oral challenge with antigen. They injected a small amount of serum from an allergic subject into a healthy person and then fed the latter the antigen to which the allergic subject was sensiti/e. They found that approximately 85% of healthy subjects responded 1 to 2 hours after the food ingestion with an inflammatory reaction at the site of passive transfer. Enough immunologically active antigen was absorbed into the bloodstream to reach the skin site and produce a wheal and flare reaction. Ingestion of nonspecific antigens caused no reaction. This then provided an explanation of how food antigens might induce asthma after intestinal . absorption if reagins were fixed to the lung. That IgE antibodies become fixed to mast cells in the lung is now well recognized.
Perhaps the next studies of real significance were those of Ishizaka, Ishizaka, and Hornbrook (10) , who demonstrated that reagins actually are antibodies and that they belong to a new class of immunoglobulins, which was called gamma E globulin and more recently has been named IgE (11). In 1967 Johansson, Bennich, and their co-workers (12, 13) in Sweden described the first patient with IgE myeloma and isolated the myeloma protein, permitting study of many of its physicochemical properties. They also performed the first quantitative studies of serum IgE levels and developed a radioimmunoassay for measuring specific antibodies of the IgE variety (14, 15) . These and the continued studies of Ishizaka and Ishizaka (16) (17) (18) have contributed greatly to our knowledge of this immunoglobulin and its relationship to allergy. Some of the physicochemical properties of IgE are listed in Table 1 , and some of its biological properties in Table 2 . We know that plasma cells are the major site of synthesis of IgE, just as they are the site of synthesis of other immunoglobulins. Small amounts of IgE are formed in the spleen and peripheral nodes, but a high proportion of IgE-forming plasma cells is found in certain other areas of the body, including the mucosa and submucosa of the respiratory, gastrointestinal, and urinary tracts, and in their draining nodes. The evidence is convincing that these mucosal surfaces can secrete certain immunoglobulins independent of their production in the rest of the body. This particularly involves IgA and IgE, each of which can be produced locally without appearing in serum or on distal mucosal surfaces. It has also been shown by many investigators that, after secretion by plasma cells, IgE antibodies become selectively attached to mast cells. It is known that mast cells are present in high numbers in the respiratory and gastrointestinal tracts and in the skin. Thus we can begin to appreciate the special role of IgE in respiratory and gastrointestinal allergy. Circulating basophils are closely related to mast cells and have similar receptor sites to which IgE becomes bound. This is best shown by fluorescent antibody or radioautographic methods that use antiserums specific to the heavy chain of IgE.
Interesting studies have been carried out by Sullivan, Grimley, and Metzger (19) at the National Institutes of Health, with a special electron microscopic method. They formed hybrid antibody molecules that had binding sites for both IgE and ferritin, and used these antibodies to study surface receptors for IgE on two groups of human basophils, some passively sensitized by serum of high IgE content, some not. Small, electron-dense particles indicated the location of surface-fixed IgE molecules, which were often found in a patch-like distribution. It was calculated that a maximum of 400 000 receptor sites for IgE might exist on a single basophil. It is not known whether the patchy distribution of IgE on electron micrographs is a true representation of the in-vivo surface distribution of the molecules, since it has been shown in other systems that antibodies to cell surface proteins may cause these proteins to migrate together into a patch-like pattern. Ishizaka and others have estimated that the usual number of IgE molecules per basophil is 5 to 40 000, and it is well known that all of the IgE receptor sites are seldom occupied by IgE molecules. A rare exception is found in patients with E-myeloma.
Some of the biological properties of IgE were studied by Ogawa and colleagues (20) . The biological half life of IgE in a patient with E-myeloma was found to be 5 days, much shorter than the half life of IgG but similar to that of IgD and IgA. The half life of IgE is even shorter in normal subjects (about 2 to 3 days). The catabolic rate of IgE in the patient with myeloma was reported to represent 16% of the serum IgE pool per day, and was even greater than this in normals (39%). Such a pattern is unique to IgE and IgD. In both cases a high serum level was accompanied by a slow catabolic rate and retarded elimination of the immunoglobulin from the vascular pool.
Gamma E immunoglobulin may also differ from IgG in the proportion that may represent specific antibody to a single antigen. It is rare indeed to find in humans that more than 1 % of the IgG is directed to a single antigen. With IgE it is probably not rare for 10% or more of the molecules to be directed toward a specific antigen. Gamma E immunoglobulin antibodies can be induced by low doses of antigen in animals. Humans exposed to allergens in minute amounts often make predominantly IgE antibodies, but they sometimes have detectable amounts of antibody of other immunoglobulin classes. Gamma E immunoglobulin seems to be stimulated preferentially by exposure to antigens at sites where increased numbers of IgE-containing plasma cells are present, as in the respiratory and gastrointestinal tracts.
Vaz and associates (21) have shown, with lowdose stimulation by antigen, that the IgE response of inbred strains of mice varies according to their H-2 haplotype.
SERUM LEVELS OF IgE
Let us now consider the serum levels of IgE at different ages and in various diseases. Berg and Johansson (22) made the first studies and reported the level in newborn children to be a few micrograms per 100 ml, or 20 to 40 ng/ml. The serum level in normal newborns is now considered usually to be under 5 ng/ml. The level increases gradually during the first year of life and thereafter, until it reaches its peak in adolescence or early adulthood. After this there is a gradual decline through the remainder of life. This pattern contrasts with the progression of levels of IgG, wherein newborn babies have a level similar to that of their mothers because of transfer via the placenta. The level of maternally transferred IgG then falls progressively, so that at 2 to 4 months of age there often is less than half the adult value. The level then steadily increases until 5 to 8 years, when an adult level is reached and remains throughout childhood. Gamma M immunoglobulin levels project a still different curve, increasing rapidly from a base-line value of 1 to 20 mg/100 ml at birth to more than half the adult level (over 50 mg/100 ml) at 3 months and attaining the adult level at 5 to 6 years. Gamma A immunoglobulin and IgD curves are almost identical to those of IgE, the difference being that IgD levels are more than a hundred times those of IgE, and IgA levels in turn are a hundredfold greater than those of IgD. Agerelated variations of the five immunoglobulin classes are summarized in Figures 2 and 3 .
Certain conditions in humans seem to be associated with elevated levels of IgE (23, 24) ; some of these are listed in Table 3 . They include the atopic types of allergic disease; parasitic infestations (particularly those with tissue invasion and eosinophilia); hypersensitivity pulmonary aspergillosis; the WiskottAldrich syndrome; Laennec's cirrhosis; idiopathic pulmonary hemosiderosis; celiac disease; and a syndrome recently described by Buckley, Wray, and Belmaker (25) involving high IgE levels (particularly high in children), frequent infections (especially pyogenic dermatoses), and suppressed cellular and humoral immune responses. An interesting disease in which involvement of IgE has recently been considered likely is the nephrotic syndrome; subjects with this disorder often do not have high serum levels of IgE, although their mean level may be significantly greater than the level of age-matched controls (26) . Several authors have suggested that there is a relation between pollen seasons or food allergen ingestion and proteinuria. One study of nephrotic kidneys by fluorescent microscopy has suggested the presence of deposits of IgE in the glomerular capillary walls in a high percentage of cases of idiopathic nephrosis, but not in other kidney diseases or in normal subjects (27) .
A number of conditions (Table 4) are associated with low serum levels of IgE, including infancy, most cases of congenital and acquired agammaglobulinemia, and some cases of dysgammaglobulinemia, particularly those with an absence or marked reduction of IgA (28, 29) . Some agammaglobulinemic subjects, however, have normal or high IgE levels. I have examined the serums of three such subjects, two of whom were teenage brothers with congenital agammaglobulinemia. The IgE level was normal (600 ng/ml) in one of the brothers and elevated (1500 ng/ml) in the other. Both had chronic rhinitis and chronic bronchitis, and one had bronchiectasis, yet neither had the life-threatening infections, connective tissue disorders, or liver disease that have often been reported in subjects with congenital agammaglobulinemia.
Augustin and Chandradasa (30) found a low mean level of serum IgE in cancer patients. They also found that surgical patients had low IgE levels, intermediate between those of the cancer patients and the healthy controls. Workers at the Children's Asthma Research Hospital in Denver have suggested that long-term corticosteroid administration in asthmatic children may lower the serum IgE level (31) .
MECHANISM OF ACTION
Let us now look into the question of the specific mechanism of action of IgE and how this may relate to the production of asthma. The following steps seem to occur. First, there is fixation of IgE to mast cells or basophils in proportion to the number of IgE receptors on each cell, the receptor avidity for IgE, and perhaps the serum IgE concentration. If there is a sufficient density of IgE antibodies of a selected specificity to allow bridging between antibodies by single antigen molecules, it is believed that there is a change in conformation of the Fc part of the fixed IgE molecules. This in turn is thought to stimulate an enzymatic reaction sequence in the mast cell or basophil, leading to release of histamine, of the slow-reacting substance of anaphylaxis, of substances chemotactic for eosinophils (32) , and perhaps of other chemical mediators. A similar sequence occurs if anti-IgE is applied to a cell that has IgE molecules on its surface. Finally, it should be mentioned that antigen binding by IgE involves competition from other immunoglobulins, and perhaps also from lymphocytes containing antigen receptors. All of these react with antigen according to their density in the surrounding milieu and their avidity for antigen. The relative proportions of each type of antibody and involved cell receptors are probably important determinants of the type of immunologic response that will occur. If IgE antibodies are effectively unopposed, the result may well be an immediate type of hypersensitivity response. This feature of antibody competition for allergen forms one theoretical basis for attempts to hyposensitize patients. Thus, immunotherapy is often considered an attempt to stimulate preferentially the production of blocking antibodies, largely of the IgG class but perhaps also IgA, IgM, and IgD. It is believed that these antibodies will compete for antigen and foster its elimination without producing allergy symptoms.
When normal white blood cells are exposed to ragweed antigen, an insignificant amount of histamine is released. But if these cells are first exposed to serum containing reaginic antibodies to ragweed antigen, are washed, and then exposed to the antigen they release a significant amount of histamine. In contrast, untreated normal cells release histamine when exposed to an antiserum to IgE, and they release even more after pretreatment with either reaginic or E-myeloma serum.
Factors that can modulate the release of histamine and slow-reacting substance of anaphylaxis from basophils and mast cells include the concentration of histamine itself, as well as the presence of hormones and drugs that alter the cellular content of cyclic adenosine 3', 5'-monophosphate (cyclic AMP). An increased concentration of cyclic AMP in the cell inhibits the release of chemical mediators. Epinephrine and isoproterenol are beta adrenergic stimulants that act through adenyl cyclase to cause an increased concentration of cyclic AMP. Prostaglandins Ei and E 2 are also potent stimulators of cyclic AMP accumulation in the cell. Theophylline and aminophylline, on the other hand, inhibit an enzyme, phosphodiesterase, that is responsible for the conversion of cyclic AMP into 5-AMP. When phosphodiesterase is inhibited there is a similar increase in the concentration of cyclic AMP and an inhibition of mediator release. In contrast, beta adrenergic blockage with propranolol or alpha adrenergic stimulation may lead to decreased cellular cyclic AMP and readier release of the mediators. The effects of two different agents that alter cyclic AMP concentration by different mechanisms may cancel one another or may be additive. For example, the combined activity of isoproterenol and theophylline, or of prostaglandin E x and theophylline, is much greater than that of either alone (33) .
SURVIVAL ADVANTAGES?
In conclusion, let us consider some of the possible survival advantages of IgE.
As mentioned, in rats IgE antibodies help to combat parasitic infestations, and it may be that in man they act similarly. In allergic subjects they certainly contribute to the elimination of allergenic materials from the gastrointestinal and respiratory tracts via coughing, vomiting, and diarrhea. It has also been observed that "atopic" subjects exposed to organic dusts such as moldy hay or pigeon droppings tend to get bronchospasm and coughing, and that this discourages continued contact and decreases the chance of insidious development of pulmonary fibrosis, as occurs in nonatopic farmers or pigeon breeders. It has been speculated by some that IgE may be helpful in the elimination of newly appearing clones of malignant cells. The possible association between low levels of IgE and cancer has been mentioned.
Other possible survival advantages of IgE are more speculative but deserve mention. It is interesting that IgE is the most efficient immunoglobulin in causing the antigenic release of chemical mediators from mast cells and basophils. I am tempted to suggest, on the basis of personal observations of allergic patients, that through this mechanism IgE antibodies may provide the general population with one of the best indicators it has of potential dangers in the environment, such as inhaled smoke, dusts, and even such pollutants as occur in the Los Angeles smog. Some asthmatic patients are very sensitive to tobacco smoke and others react excessively to auto exhaust or smog. I wonder whether those who are hypersensitive may in fact be warning lights to the rest of the population that there is an ill wind blowing. Can we benefit from the misfortune of these patients? Are they like the canaries used by coal miners to forewarn of imminent danger? We all are now aware of the dangers of cigarette smoking. Thirty years ago tobacco smoke made certain asthmatics very ill, but few suspected its extensive role in human disease.
There are many instances of allergic patients and their families migrating to new areas hoping to avoid being bothered by inhaled substances of various kinds, including fungi, pollens, and chemical fumes. It seems possible that the IgE antibodies of asthmatics, as well as the lower levels present in many who are not obviously allergic, may be responsible for significant migrations away from population centers and the pollution inherent in crowded places. Since 25% to 30% of the population shows evidence of clinical allergy during life, hypersensitivities in general and IgE in particular might have been involved in the final distribution of many populations over the centuries. Could such effects have survival advantages for the human race? Certainly within a decade we shall have a much better understanding about the special survival advantages of this biologically very active immunoglobulin.
Control of Bronchial Smooth Muscle and its Relationship to Asthma
Dr. Beall: The reversible element of the bronchial obstruction in asthma is probably largely due to bronchial smooth muscle contraction. An understanding of the neural and humoral control of this smooth muscle (Table 5) should give us important information about the variations in asthmatic symptoms (34) .
AUTONOMIC NERVOUS SYSTEM
Although sympathetic innervation is present in the lung, its role in control of the bronchial smooth muscle seems small. Stimulation of sympathetic nerves releases norepinephrine, a potent alpha adrenergic stimulator and a weak beta stimulator. Exhibition of norepinephrine ordinarily produces bronchodilation, apparently because there are few alpha receptors and many beta receptors in the bronchi.
Humoral factors, particularly those with beta adrenergic activity, are probably more important than sympathetic nerves in controlling bronchial smooth muscle, which relaxes under the influence of beta adrenergic stimulators such as isoproterenol. The major source of beta adrenergic stimulation in humans is epinephrine, apparently almost entirely derived from the adrenal medulla. Little is known about the function of the adrenal medulla and the pattern of epinephrine secretion in health and disease. Further studies of the relationship of epinephrine and adrenal medullary function to asthma are much needed.
Parasympathetic innervation reaches the bronchi via the vagus nerve. Stimulation produces bronchoconstriction. There is apparently some parasympathetic tone normally present in bronchial smooth muscle, and variations in this tonic constriction may account for the variations in airway resistance that can be seen during a 24-hour period. In general, the asthmatic's airway resistance is greatest at night and least in the morning, apparently responding to a circadian rhythm of the parasympathetic nervous system. These findings partially explain the characteristic nocturnal dyspnea of asthma.
BRONCHIAL REFLEXES
The parasympathetic nervous system is also involved in mediating a number of bronchial reflexes that can either cause or intensify asthma. Respiratory mucosal irritation by such stimuli as sulfur dioxide, cold air, dust, rapid or turbulent air flow, or coughing can produce bronchoconstriction. Sensory receptors located in the mucosa of the nose and the large airways are responsible. Both the afferent and efferent limbs of the reflex are carried in vagal fibers. The vagal effectors cause the bronchial smooth muscle to constrict. Such reflex bronchoconstriction occurs in normal humans, but the changes in airway resistance are small and do not produce symptoms. In contrast, reflex bronchoconstriction is one of the most common causes of symptoms in asthmatic patients. Understanding this difference between normal humans and asthmatic patients may be a key to an understanding of the disease. Experiments performed by Simonsson, Jacobs, and Nadel (35) have provided one possible explanation: removal of the mucosa from an animal's trachea can facilitate reflex bronchoconstriction, an effect probably due to exposure of tracheal sensory receptors, thereby lowering their threshold. This model may explain the origin of some types of asthma, in particular of those that occur during the course of another pulmonary disease, such as chronic bronchitis.
Dr. Tashkin will be discussing the varied effects of C0 2 on the bronchi. Hypoxia, by stimulating the carotid bodies, produces reflex bronchoconstriction mediated by vagal efferents. This is probably an important means of intensifying an asthmatic attack once it has begun, since hypoxemia is always present in all but the mildest asthma. This phenomenon was used as justification for the removal of the carotid bodies, a procedure that has subsequently been discarded because of its hazards and lack of effectiveness.
OTHER FACTORS
Histamine and the slow-reacting substance of anaphylaxis are both present in the lung, probably largely in the mast cells from which these substances are released by immunological events (36) . Since release of these substances produces bronchoconstriction, these mediators can account for the bronchoconstriction that follows antigenic challenge in sensitized patients. It is uncertain whether they are further involved in bronchoconstriction that cannot be related to exposure to allergens.
It is difficult to propose much of a role for serotonin in bronchoconstriction, except in the wheezing sometimes associated with pulmonary embolism. Serotonin may then be released from platelets trapped in the embolus or associated thrombus. Although this is an interesting phenomenon, it seems to be rare.
CENTRAL NERVOUS SYSTEM
It has become quite clear through experiments using suggestion and hypnosis that influences from the central nervous system can directly alter airway resistance in asthmatics.
In a hypnotic trance appropriate suggestion can increase or decrease airway resistance in patients with asthma (37) . Presumably, this change is mediated through the vagus nerve. The change in airway resistance must be due to changes in smooth muscle, since it is unlikely that suggestion much alters the mucus plugs found in the bronchi of severe asthmatics. It has also been shown that medications are more active when reinforced by suggestion; this is an important therapeutic point (38) .
PATHOGENESIS OF ASTHMA
A number of interesting ideas are currently stimulating research in asthma (Table 6 ). First is the hypothesis that asthma is due to increased parasympathetic activity, which is usually expressed as a decrease in threshold to reflex bronchospasm, possibly with some central modification (35) . Another very important idea is that asthmatics have a partial beta adrenergic blockage (39) . This hypothesis proposes that the normal circulating amounts of epinephrine are not effective in overcoming parasympathetic tone. There is a good deal of evidence that something is wrong with the response of asthmatics to beta stimulators, but it must be recalled that these patients have almost invariably received sympathomimetic drugs for a long time, an antecedent that probably affects their cardiac, metabolic, and pulmonary responses to such stimulators. Third, there is some evidence of a deficiency of beta adrenergic stimulators in asthmatics (40) ; there seems to be a deficiency of epinephrine release by asthmatics in response to stress. Fourth, the release of histamine and slow-reacting substance of anaphylaxis from IgEsensitized mast cells reacting with antigen is obviously important in some situations; this sequence of events may account for asthma induced by allergens, but it does not appear to be sufficient to explain all asthmatic episodes. Clearly, these hypotheses are not mutually exclusive. Enough evidence exists already to establish a role for each. Their synthesis awaits the future.
Mechanisms of Arterial Hypoxemia
Dr. Brian J. Whipp*: Drs. Beall and Heiner have suggested causes for the bronchial constriction observed in bronchial asthma. What I should like to do is attempt to describe the consequences of that bronchoconstriction, especially with respect to the distribution of inspired gas and its effects on arterial blood gas tensions.
In attempting to elucidate the mechanism of arterial hypoxemia of any clinical cause at sea level the clinician is faced with what, in the broad spectrum of science, must be regarded as a relatively simple task. All he has to do is to distinguish among 15 alternatives. The task is further simplified by the fact that these alternatives involve only four independent processes, which may be potentially present in any combination. To establish an appropriate frame of reference for the hypoxemia of asthma, I should like to present a brief overview of the four independent causes of hypoxemia.
HYPOVENTILATION
Under steady-state conditions, and with all the cardiac output undergoing gas exchange, arterial 0 2 and C0 2 tensions (Po 2 , Pco 2 ) are defined exclusively by the overall effective alveolar ventilation (VA), pulmonary capillary blood flow (Qc), and the mixed venous gas concentrations. Under conditions in which the volume of 0 2 delivered to the alveoli per minute is insufficient for the uptake requirements of the blood entering the pulmonary capillary bed, a fall of alveolar Po 2 and arterial Po 2 results.
As a cause of arterial hypoxemia, this mechanism (that is, alveolar hypoventilation) is probably the easiest to understand, either conceptually or intuitively. An additional consequence of hypoventilation is increased alveolar Pco 2 and arterial Pco 2 . Arterial C0 2 tension may be considered to be the best single index of adequacy of overall alveolar ventilation.
DIFFUSION LIMITATION
The second cause is a consequence of the fact that for some reason the erythrocyte has not been exposed to the gas exchange surface of the lungs for sufficient time to reach equilibrium with the gas tension in the alveolus. For the normal person at rest erythrocytes remain in the pulmonary capillary bed (or exposed to the gas exchange zone of the lung) for an average of approximately 0.75 seconds. The exponential uprise of arterial Po 2 , however, proceeds at a rate that requires only approximately 0.3 seconds for "equilibrium." Therefore, a two-to three-fold increase in pulmonary capillary blood flow can be potentially accommodated by the lung without arterial hypoxemia resulting from insufficient time for 0 2 diffusion equilibrium. In addition, the normal lung is able to "recruit" additional functional pulmonary capillaries and distend the available capillaries, thereby increasing further the ability to reach diffusion equilibrium for 0 2 at high cardiac outputs. In fact, trained athletes may increase their cardiac output five to six times without evidence of arterial hypoxemia.
In the case of a patient with compromised pulmonary vasculature (who is unable to recruit additional pulmonary capillaries), despite the fact that at rest the erythrocyte may be in the pulmonary capillary bed long enough for 0 2 equilibrium (thereby resulting in normal arterial Po 2 ), the increased cardiac output with even light work may cause the erythrocyte to leave the pulmonary capillary gas exchange surface before sufficient time has elapsed for 0 2 equilibration. The consequence is arterial hypoxemia which becomes more pronounced as the work rate, that is, the cardiac output, is progressively increased.
Another cause of insufficient time for 0 2 diffusion equilibrium is increase of the length of the diffusion pathway for oxygen from the alveolus to the capillary bed, as for example where the alveoli are partially filled by some exudate. This reduces the rate constant of the exponential increase of Po 2 . Thus, despite the fact that the erythrocyte is in the pulmonary capillary bed for what would "normally" be sufficient time for diffusion equilibrium, the increased diffusion path length may cause the blood to leave * Department of Physiology, and Harbor General Hospital, Torrance, California. Established Investigator of the American Heart Association. the pulmonary capillary bed with a Po 2 smaller than the alveolar Po 2 . This hypoxemia will also be exacerbated by increased cardiac output.
In contrast, the high solubility of C0 2 in blood allows C0 2 equilibrium even under conditions in which 0 2 exchange is markedly impaired.
RIGHT-TO-LEFT SHUNT
Any pulmonary arterial, or systemic venous, blood that bypasses the pulmonary gas exchange surfaces and that mixes with arterialized blood from the pulmonary capillary bed must both reduce the arterial Po 2 to values below, and increase the arterial Pco 2 to values above, end-pulmonary capillary blood. The net effect on arterial Po 2 , however, will be greater. This is because of [1] the wider mixed venous to arterial gradient for Po 2 (approximately 50 to 60 mmHg at rest) than for Pco 2 (approximately 6 mm Hg at rest); [2] the slope of the gas content-topartial pressure curve being steeper for C0 2 than for 0 2 ; and [3] arterial Pco 2 being regulated at approximately 40 mm Hg by increased ventilation under these conditions, whereas, functionally, low arterial Po 2 is not a good ventilatory stimulant until arterial Po 2 approximates 60 mm Hg (with normal arterial Pco 2 and pH). Arterial hypoxemia is therefore an inevitable consequence of such right-to-left shunts, whether they occur by intracardiac or intrapulmonary routes. Knowledge of the shunt fraction of the total cardiac output and the contents of 0 2 in mixed venous and pulmonary end-capillary blood allows prediction of the content of 0 2 in arterial blood. The following equation* represents the relationship between the variables:
Qs
CaOo -Cc0 2 , -= , where Qt CvQ 2 -CcQ 2 Qs is the shunted blood flow; Qt is the total cardiac output; and Ca0 2 , Cc0 2 , and Cv0 2 represent the 0 2 contents of arterial, end-capillary, and mixed venous blood, respectively. It is more usual, however, to measure (or estimate) the quantities of 0 2 in the blood components in order to derive the shunt fraction of the cardiac output.
MALDISTRIBUTION OF ALVEOLAR VENTILATION (VA) AND LUNG PERFUSION (Q)
Under conditions in which the overall, or average, VA is approximately equal to the overall, or average, Q (that is, a normal average VA/Q) the lung may still have regions of high VA/Q, normal VA/Q, and low VA/Q interspersed. The consequence of such a distribution is that blood from the high VA/Q region will reflect hyperventilation with high Po 2 and low Pco 2 , that blood from the normal VA/Q regions will have normal values for Po 2 and Pco 2 , and blood from the low VA/Q region will reflect hypoventilation with low Po 2 and high Pco 2 . The overall arterial Po 2 and Pco 2 will therefore result from averaging the total contents of the gas from each "stream" in proportion to the blood flow from each region.
Since the dissociation curve for C0 2 may be considered "linear" in the physiological range, the mixing of high and low Pco 2 blood can result in normal average Pco 2 (depending on the mixing ratio). Any variation from "normal" arterial Pco 2 is usually sensed by peripheral (aortic and carotid bodies) and central (medulla oblongata) chemoreceptors, which effect regulation of arterial Pco 2 by modifying ventilation. Therefore, unequal distribution of VA with respect to Q does not usually lead to an elevated arterial Pco 2 .
In contrast, the blood dissociation curve for 0 2 is nonlinear (Figure 4 ). The result is that low VA/Q regions lead to both low Po 2 and content of 0 2 , whereas high VA/Q regions lead to high Po 2 with only small increases of 0 2 content above the normal value because the 0 2 dissociation curve is relatively flat in this range. Mixing blood from low VA/Q regions with blood of high VA/Q regions will therefore result in an average Po 2 that is "weighted" toward the low VA/Q blood. But the value for the mean Po 2 will depend on the volumes of blood from each "region" that stream into the mixed arterial blood per unit of time. Thus, the high VA/Q regions (even if, as in Figure 4 , their hemoglobin is completely saturated) are functionally unable to "compensate" for the regions of low VA/Q. The effect is that under conditions in which the overall VA/Q is normal (that is, no hyperventilation), uneven distribution of VA with respect to Q results in arterial hypoxemia.
HYPOXEMIA AND BRONCHIAL ASTHMA
One initial functional disturbance in bronchial asthma is widespread constriction of small bronchial airways (41) , with the resulting maldistribution of ventilation being readily demonstrated (42) . Hypoxemia without associated hypercapnia is commonly observed in asthma (43) , but hypoxemia with hypoor hyper-capnia (44) may also be manifest.
Since the most common blood gas combination in bronchial asthma is arterial hypoxemia with normocapnia or hypocapnia, hypoventilation may be ruled out as the predominant cause of the hypox- . Note that the average arterial P02 is "weighted" toward the PO, of the low VA/Q region due to the nonlinearity of the Hb-02 dissociation curve. See text for further discussion. To avoid further elaboration of the figure, positional shifts of the dissociation curve-due, for example, to differences in pH of the mixing blood streams-are neglected.
emia. Of the three remaining categories, diffusion limitation is improbable as a common cause, as numerous investigators (45, 46) have found normal diffusing capacity for carbon monoxide in asthma despite hypoxemia and reduced forced expiratory volumes. Maldistribution of VA with respect to Q is the predominant cause of asthmatic hypoxemia, despite retention by the lung of some ability to redistribute Q away from the relatively hypoventilated regions (47) . As the hypoxemia may not be sufficient to stimulate ventilation, the subject may not be hypocapnic. Areas of the lung with severe bronchospasm may become atelectatic, thereby providing some additional intrapulmonary shunting.
If the resulting hypoxemia is sufficiently marked, hypocapnia may be present due to increased ventilation; however, hypocapnia may also be noted with moderate hypoxemia in this group of patients. The exact mechanism is unclear but may be related to unusual deformation or irritation of certain lung regions or to some other unrecognized phenomenon.
If because of widespread bronchospasm the overall resistance to airflow is sufficiently increased, so that the energetic requirements of the force-generating units of the respiratory muscles become inappropriately high, then arterial Pco 2 may increase. Elevations of arterial Pco 2 in the presence of hypoxemia reflect superimposed hypoventilation. Such blood gas tensions have been noted in subjects in status asthmaticus (44) .
In conclusion, the hypoxemia of bronchial asthma results predominantly from uneven distribution of VA with respect to perfusion, with some right-to-left intrapulmonary shunting possibly occurring through regions of atelectasis. Normocapnia is a usual finding, but hypocapnia may also be observed. Hypercapnia can also become manifest in severe bronchial asthma.
Exercise-Induced Bronchospasm
Dr. Donald P. Tashkin*: In 1952 Pearson (48) first identified a group of asthmatics who experienced dyspnea not during but only after exercise, in association with marked worsening of airways obstruction. Subsequently, exercise-induced bronchospasm has been reported in a widely variable proportion of asthmatic subjects by different investigators. These differences in reported prevalence are likely due to factors such as patient selection; duration, intensity, and type of exercise; previous exercise during the same day; and sensitivity of the methods used to detect bronchospasm.
Jones, Bus ton, and Wharton (49) found that asthmatic children improved their ventilatory flow rates after exercising for short periods of 1 to 2 min. When these same subjects exercised for longer periods of 5 to 10 min, however, nearly all experienced bronchial obstruction within 10 min of the completion of exercise, with a gradual recovery over 30 to 60 min. By subjecting asthmatic children to incremental exercise loads, by using a cycloergometer on separate days, others have found a threshold exercise intensity below which bronchospasm does not occur (50) . In the same subjects, however, similar work loads applied for similar time intervals with different modalities (stair climbing vs. bicycling) have been shown to have variable effects in inducing asthma (51) . Interpretation of studies of exercise-induced bronchospasm is further complicated by the finding of McNeill and co-workers (52) that repeated periods of exercise during the same day may result in a progressively diminishing degree of postexercise bronchospasm. In normal subjects the same authors found that exercise did not produce a reduction in spirometric flow rates but did cause a significant increase in airway resistance, a more sensitive indicator of bronchial narrowing. These changes were quantitatively less marked than those noted in asthmatics but had similar temporal characteristics, suggesting that a similar mechanism may be operating in normals.
Physical fitness and the severity of the resting ventilatory abnormality do not seem to be related to the occurrence or degree of postexertional bronchospasm. In fact, dyspnea and bronchospasm after exercise may be the only clinical manifestations of otherwise asymptomatic asthma (52) .
The manner in which pharmacologic agents modify the postexercise changes and observations of associated physiological and biochemical changes (Table  7) may provide clues to the mechanism of exerciseinduced bronchospasm.
Bronchodilators partly or completely prevent postexercise bronchial narrowing (53) , indicating the obstruction to be due to active constriction of bronchial smooth muscle rather than to exercise-induced bronchial mucosal edema or blood vessel engorgement. The finding that propranolol, a beta adrenergic blocker, does not modify the response (54) suggests that postexertional asthma is not due to exerciserelated inhibition of resting sympathetic bronchial smooth muscle "tone."
The possibility that exercise causes changes in the bronchi, which lead to the release of mediators of anaphylaxis, has been considered. Since disodium cromoglycate has been shown to inhibit release of histamine and slow-reacting substance of anaphylaxis from tissue mast cells, the finding of a significant inhibitory effect of disodium cromoglycate on exercise-induced bronchospasm (55) favors this possibility. The lack of protective effect of large doses of antihistamine (52) , however, suggests that postexercise bronchoconstriction is at least not exclusively histamine-mediated.
The failure of atropine to block exercise-induced bronchospasm (51, 52, 54) suggests that the bronchospasm is not neurogenically mediated by cholinergic efferents. The time delay in the onset of bronchospasm also argues against a neurogenic reflex mechanism. Crompton (56) has described an unusual patient in whom bronchoconstriction followed exercise-or C0 2 -induced hyperventilation; atropine but not isoproterenol prevented this reaction.
A favorable effect of hypnosis (37, 57) suggests that in some patients a cortical or emotional factor may be involved.
BLOOD GAS CHANGES AND EXERCISE-INDUCED BRONCHOSPASM
Since voluntary hyperventilation associated with reductions in arterial Pco 2 to levels of less than 20 to 30 mm Hg has been shown to produce significant bronchospasm in normal man, some investigators have suggested that postexercise bronchospasm is due to hypocapnia secondary to the hyperventilation of exercise. Evidence in support of this hypothesis is the finding that moderately severe respiratory alkalosis develops in some patients with postexertional dyspnea (58) and that C0 2 breathing prevents and corrects exercise-induced bronchoconstriction (51, 58) . On the other hand, we have observed only minimal reductions in arterial Pco 2 during the development of exercise-induced bronchospasm ( Figure 5 ), as have other workers (50, 59 ). In addition, we have found that voluntary hyperventilation associated with reductions in arterial Pco 2 similar to those observed in the same patients during exercise-induced bronchospasm caused only mild and nonsignificant increases in airway resistance. Furthermore, hypocapnia-induced bronchoconstriction, at least in normal man, is largely blocked by atropine, whereas exercise-induced bronchospasm generally is not. We would conclude, therefore, that hypocapnia is probably not responsible for the bronchoconstriction that occurs in most patients with exercise-induced bronchospasm, although there undoubtedly are some patients similar to those reported by Ferguson, Addington, and Gaensler (58), in whom bronchospasm is induced by inappropriate Although there is some evidence that hypoxemia, which has been observed to a variable degree in association with postexercise bronchospasm, may cause a moderate worsening in ventilatory flow mechanics in normal and bronchitic subjects, it has been well demonstrated that breathing very hypoxic gas mixtures has no effect on airway resistance in patients who previously had exercise-induced bronchospasm (51) . In patients with exercise-induced bronchospasm we have shown an initial increase in arterial Po 2 early in the postexercise period, followed by a slight fall once the bronchoconstriction has become established (Figure 5 ), which suggests that hypoxemia is not the cause of the bronchospasm but is more likely the result of the uneven distribution of ventilation associated with asthmatic bronchoconstriction.
Noting a similarity in the time-course of bronchospasm and metabolic acidosis after exercise, Seaton and associates (60) have suggested that the lactic acidosis of exercise might be responsible for the bronchoconstriction, perhaps by stimulating the formation or release of bradykinin or other bronchoactive material. Others, however, have observed only a very mild reduction in arterial bicarbonate concentration during exercise-induced bronchospasm (50) , suggesting that metabolic acidosis is not a necessary condition for the development of bronchospasm. Further, we have shown that respiratory acidosis produced by C0 2 breathing does not cause bronchoconstriction in asthmatics (61) , although a constrictor effect of acidosis could conceivably be masked by a possible dilator effect of C0 2 per se. If acidosis does contribute to the bronchospasm following exercise, studies in which the acidosis is prevented or corrected by infusion of base should clarify the issue.
The possibility that the increased ventilation of exercise might have a mechanical bronchoconstrictor effect has been discounted because of the failure of subjects with exercise-induced bronchospasm to develop bronchospasm during C0 2 -induced hyperventilation (52) . Recently, however, Chan-Yeung, Vyas, and Grzybowski (62) have found marked bronchospasm during isocapnic, voluntary hyperventilation to levels of ventilation higher than those previously studied and similar to those achieved during exercise sufficient to induce bronchospasm. These results are of particular interest because of the findings of Piper and Vane (63) that sensitized guinea pig lungs re-lease bronchoactive mediators when subjected to trauma. Consequently, it is tempting to hypothesize that the increased ventilation of exercise may traumatize the lungs of asthmatics sufficiently to cause the release of bronchoconstrictor substances. The inhibitory effect of disodium cromoglycate on exerciseinduced bronchospasm, the time lag on onset of postexertional asthma, and the decline in the magnitude of the phenomenon with repeated exercise, suggesting depletion of tissue stores of mediator during successive bouts of exercise, are all consistent with this hypothesis.
Dr. Beall: I hope that we have been able to transmit the excitement we feel about current progress in asthma. It is now possible to understand how many of the symptoms arise. Exercise-induced bronchospasm, for instance, is a relatively common problem for asthmatic patients. Knowledge of the mechanism and frequency of these episodes makes it possible to relieve them by administering bronchodilator drugs before exercise or by advising physical regimens involving short bursts of activity rather than prolonged exercise.
An even more important result of this progress will be the development of better therapy, not only new drugs but, more importantly, methods for control of the asthmatic responses to allergic and psychological influences. • Requests for reprints should be addressed to Gildon N. Beall, M.D., Harbor General Hospital, 1000 W. Carson St., Torrance, CA 90509.
Selecting Medical Students
THERE IS no stereotype of the temperament of the doctor; rather are there stereotypes of many different kinds of doctors. When we think of a good general practitioner, we think of one of the first presidents of your sister college in Britain, the kindly, humane, rubicund figure of Will Pickles of Wensleydale. Of psychiatrists and psychiatry, it is said this is the study of the id by the odd. Surgeons are jolly, butcher-like figures, who are addicted to golf, yachts, or horse-racing. Physicians are hatchet-faced men of melancholy visage, supposedly bulging with brains. Medical administrators develop a peremptory, quasimilitary style of action. Pathologists are disdainful, aloof men, faintly contemptuous of those who treat with the living. Paediatricians are inclined to be obsessive about their charges; obstetricians are notoriously urbane and affluent. The range of interests and responsibilities and the kinds of skills required of modern doctors are such as to cast serious doubts on the manner in which universities select students for entrance into their medical faculties. It is a spectrum of qualities with which we are dealing in doctoring; at one end there are persons who, almost at the very outset of their training, are destined to become problem-solving bench workers, persons whose interest in people as such is almost casual and even unnecessary, while at the other end there are excellent people who do not know a spectrophotometer from a gas chromatograph, yet who do a superbly skilled job of managing gravely disturbed people such as drug-taking adolescents, or depressed pensioners, or antisocial psychopaths.
Faced with the need for diversity in the end product of medical training, is it not illogical that we should be so narrowly restrictive in the choice of young men and women for entrance into medicine? Almost exclusively these are now young people who have, from the age of 15 years, specialized in chemistry, physics and mathematics, to the extent that they might otherwise be expected to take good honours degrees in these subjects. Psychologists who have looked into these matters describe this kind of student as "problem-orientated", in contrast to the kind of person who is "human-orientated"; the latter is more likely to have an early interest in language and literature and the social sciences. It is obvious that, in the great and broad enterprise of medicine, both kinds of people are required: insightful psychiatrists who are biochemical dunces are as important in our kinds of society as biophysical geniuses who can scarcely distinguish between acne and smallpox; for every Virchow we need a Freud; and for every Madame Curie is needed a Florence Nightingale. 
